This rule is established pursuant to 18 V.S.A. § 4752.
This rule establishes minimum requirements for Office Based Opioid Treatment (OBOT) providers to prescribe, and in defined circumstances, dispense medication to patients accessing treatment for opioid use disorder. The rule also establishes Vermont-specific requirements for Opioid Treatment Programs (OTPs) that are in addition to the requirements of 42 CFR Part 8.
-- Routine toxicological screens;
-- Random requests for medication counts;
-- Bubble-packaging of prescriptions, if in tablet form
-- Recording the identification numbers listed on the medication "strip" packaging for matching with the identification numbers during random call-backs; and
-- Observed dosing;
Determining the frequency of monitoring procedures described in Section 6.6.2.1.3 based on the clinical
treatment plan for each patient and each patient's level of stability. For patients receiving services from multiple providers, the coordination and sharing of toxicology results is required, pursuant to applicable federal and State law, federal regulations, and State rules.
-- violence
-- aggression
-- threats of violence
-- drug diversion
-- trafficking of illicit drugs
-- continued use of substances
-- repeated loitering
-- noncompliance with the treatment plan resulting in an observable, negative impact on the program, staff, patient, or other patients.
The Department may, without notice, perform an inspection, and survey OBOT providers and OTPs for compliance with this rule at any time.
13-062 Code Vt. R. 13-140-062-X
May 29, 2001 Secretary of State Rule Log #01-29
AMENDED:
May 8, 2012 Secretary of State Rule Log #12-011; April 1, 2016 Secretary of State Rule Log #16-001; July 15, 2017 Secretary of State Rule Log #17-039; 5/15/2024 Secretary of State Rule Log #24-015
STATUTORY AUTHORITY:
18 V.S.A. §§ 102, 4752; Act 195 of 2013